Imaging biomarkers of diffuse liver disease: current status

Bachir Taouli1,2, Filipe Caseiro Alves3

  • 1Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine At Mount Sinai, 1470 Madison Avenue, New York, NY, 10029, USA. bachir.taouli@mountsinai.org.

Summary

This special issue explores diffuse liver disease imaging. Experts discuss ultrasound, CT, MRI, and molecular agents, highlighting current status, limitations, and future directions for imaging biomarkers.